88IV - PR Newswire Asia's news


VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial Pivotal Phase II/III clinical trial underway, aiming for US and European market approval in 2028 A 'truly transformative' regenerative medicine targeting a multi-million patient population with no existing ... 2026-03-25T Biotechnology Computer/Electronics Health Care/Hospital Medical Equipment
From SCAN to SPARK: Galaxy Brain Scientific Enables a New Paradigm in Non-invasive, Personalized Precision Treatment for Parkinson's Disease BEIJING , March 25, 2026 /PRNewswire/ -- A research team led by Prof. Hesheng Liu, founder and Chief Scientific Officer of Galaxy Brain Scientific Inc., has published a study in Nature ... 2026-03-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis SHANGHAI , March 25, 2026 /PRNewswire/ -- Hope Medicine Inc., a science-driven, clinical-stage innovative biopharmaceutical company, announced that the first patient has been dosed in the Phase III clinical ... 2026-03-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
HKeyBio Launches HKEY-NHP-onChip™ 1.1: World's First NHP In Vitro Model for Autoimmune and Allergic Diseases The integrated organ-on-chip platform offers 10–100x cost efficiency and 80% reduction in animal use, bridging the gap&n ... 2026-03-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Discovery Life Sciences and Mindpeak Partner to Bring AI Precision to Cancer Biomarker Testing in Global Clinical Trials New alliance takes aim at inconsistent biomarker interpretation across pathologists, a persistent challenge in drug development ... 2026-03-24T Biotechnology Computer Software Computer/Electronics Health Care/Hospital
Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study in type 1 diabetes ... 2026-03-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi Biologics Reports Record 2025 Annual Results Revenue increased 16.7% YoY to RMB 21.8 billion, and revenue from continuous operations grew over 20% YoY IFRS gross profit margin expanded to 46.0% (+500 bps YoY); adjusted gross profit margin increased ... 2026-03-24T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer Appointments Reinforce Deep Technical Expertise in Biotech R&D and Capital Markets Leadership as Origin Advances Its Commercial Pipeline ... 2026-03-24T Agriculture Biotechnology
Insilico Medicine and ASKA Pharmaceutical Expand Partnership to Discover Novel Targets for Women's Health CAMBRIDGE, Mass. , March 24, 2026 /PRNewswire/ -- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced ... 2026-03-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech Receives IND Approval for SKB103, a Novel TAA-PD-L1 Bispecific ADC CHENGDU, China , March 24, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) today announced that the Investigational ... 2026-03-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology